• Blog
  • Renal Denervation Market Analysis | 2022-2028

    Renal Denervation Market Analysis | 2022-2028

    Renal Denervation Market Analysis | 2022-2028
    Report code - SR2531 Delivery - 2 Weeks
    Renal Denervation Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Op See more...

    Market Insights

    "The renal denervation market is expected to grow at a CAGR of 31.6% during the forecast period. The market was valued at US$ 600.0 million in 2021 and will reach US$ 5,396.4 million by 2028."

    Want to get a free Sample? Register Here

    Renal denervation is a minimally invasive catheter-based treatment that is used to treat resistant hypertension. In the process, radiofrequency ablation is used to burn nerves in the renal arteries. If pharmacological treatment does not result in relief, this procedure is usually used to achieve better results. The nerves in the renal artery wall are removed using high-frequency pulses or ultrasound.

    It lowers blood pressure by reducing the activity of the sympathetic kidneys. The market growth is challenged by the risks associated with post-surgery infection, the high cost of renal denervation techniques, the lack of a skilled workforce, changes in renal anatomy and long-term follow-up procedures.

    Renal Denervation Market Report Overview

    Market Size in 2026

    USD 5,396.4 million

    Market Size in 2021

    USD 600.0 million

    CAGR (2021-2026)

    31.6%

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2028

    Key Players

    Key players operating in the global renal denervation market include:

    Market Dynamics

    Benefits of Renal Denervation Therapy Devices:

    Renal denervation therapy has shown positive results in reducing hypertension. Therefore, renal denervation therapies offer benefits such as higher safety, shorter treatment times, and long-lasting effects among others, resulting in driving the market growth. Also, technological advancements in renal denervation devices contribute positively towards the market growth during the study period.

    The development of catheter-based interventions to remove renal nerves has shown positive and effective results in patients suffering from hypertension by resisting hypertensive symptoms. Moreover, catheter-based procedures are comparatively safer for the patients and facilitate the denervation of selected nerves.

    Rising Prevalence of Hypertension:

    Hypertension is very common due to many factors such as depression, stress, co-morbid conditions, and several other factors. Renal denervation therapy has always shown a positive result in managing hypertension. According to the Centers for Disease Control and Prevention (CDC), in 2020, more than 670,000 deaths in the United States had hypertension as a primary cause; and about half of the adults in the country have hypertension. Hence, a significant prevalence of hypertension contributed towards the growth of the renal denervation market over the forecast period.

    COVID-19 Impact:

    The novel coronavirus (COVID-19) rapidly spread across the globe in the year 2019. This spread was responsible for an enormous impact on people. Due to the pandemic, production across industries halted and devices used in managing and curing renal denervation were no exception, owing to worldwide lockdowns at different levels and at different times.

    Vaccination and treatment of patients have led to the reopening of manufacturing facilities, resulting in the active operation of renal denervation companies at their full-scale capacities, hence it is anticipated that the market will fully recover by the start of 2023.

    Segment Analysis

    Product Insights

    "Simplicity Renal Denervation System accounted for the largest share."

    Simplicity Renal Denervation System accounted for the largest share of the global renal denervation market in 2020. This system is being used to treat hypertension as it delivers low-level radiofrequency energy and reduces the risk of radiation on body tissues due to high-level radiofrequency. It also offers a minimally invasive procedure to treat excessive hypertension.

    In the global renal denervation industry, radiofrequency was the most frequently used technology and it was the key contributing segment in 2020. Radiofrequency renal denervation is an effective way to control resistant hypertension, and a one-time procedure is enough to lower blood pressure levels for up to two years.

    Regional Trends

    "North America is expected to remain the largest market share."

    North America renal denervation market dominated the global marketplace owing to a high number R&D activities coupled with the changing lifestyle of the population. Moreover, Asia-Pacific renal denervation market will grow at the highest growth rate during the forecast period, due to the rising number of cases related to diabetes and obesity along with a rising number of drug-resistant hypertension cases.

    Europe renal denervation market has accounted for a significant share in recent times. The regional share is attributed to the early start of this technology in the region along with the most of the devices in this market have a CE mark approval and are available for commercial purposes in the region.

    Asia-Pacific renal denervation market is estimated to grow with the high CAGR. The regional growth is attributed to the increase in awareness about the use of advanced technologies such as renal denervation systems, the presence of ample growth opportunities in terms of unmet medical needs for the treatment of hypertension and the high prevalence rate of resistant hypertension.

    Want to get a free sample? Register Here

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What deliverables will you get in this report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the Renal Denervation Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional and country level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

     

    Target Audience

    Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

    • Distributors
    • Suppliers
    • Manufacturers
    • Logistics organizations
    • Government bodies

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@Stratviewresearch.com

    Recent Developments

    The global renal denervation market competitive landscape provides details by competitor. Companies are adopting various competitive strategies to withhold strong foothold in the market. For instance:

    In April 2021, Medtronic partnered with Surgical Theater to integrate the StealthStation S8 Surgical Navigation System with Surgical Theater'sSyncAR Augmented Reality technology. This technology will help neurosurgeons to use real-time AR technology to improve visualization during difficult cranial surgery.

    In April 2021, Brattea, a renal denervation medical technology company based in China, announced the completion of US$ 20 million Series B+ financing led by Kuanping Capital, a healthcare private equity fund.

    In December 2020, SoniVie, has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the TIVUS System for renal artery denervation for the treatment of resistant hypertension.

    Frequently Asked Questions (FAQs)

    Renal denervation is a minimally-invasive catheter based treatment that is used to treat resistant hypertension. In the process, radiofrequency ablation is used to burn nerves in the renal arteries. If pharmacological treatment does not result in relief, this procedure is usually used to achieve better results. The nerves in the renal artery wall are removed using high frequency pulses or ultrasound.

    The renal denervation market is expected to grow at a CAGR of 31.6% during 2022-2028.

    The renal denervation market size was estimated at US$ 600.0 million in 2021 and is projected to reach US$ 5,396.4 million by 2028.

    Key players operating in the global renal denervation market include: Medtronic (US), Boston Scientific Corporation (US), Brattea (China), Abbott (US), ReCor Medical, Inc. (US), Johnson & Johnson Private Limited (US), Terumo Corporation (Japan), Mercator MedSystems, Inc. (US), Ablative Solutions, Inc. (US), SympleSurgical Inc. (US), SoniVie (Israel), Kona Medical Inc. (U.S.), Renal Dynamics Limited (U.K.), Otsuka Medical Devices Co., Ltd. (Tokyo).

    North America renal denervation market dominated the global marketplace owing to high number R&D activities coupled with changing lifestyle of the population.

    Asia-Pacific renal denervation market will grow at the highest growth rate during the forecast period, due to the rising number of cases related to diabetes and obesity along with rising number of drug resistant hypertension cases.